HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Thursday, 9 June 2016

New NICE appraisal process!

NICE are consulting on a new abbreviated technology appraisal (ATA) process….

"The aim of the ATA is to provide a less resource-intensive process for appraising technologies that provide similar or greater health benefits compared with those already recommended in NICE guidance for the same indication, at a similar or lower cost–for example, new drugs within an establishedtherapeutic class of treatments (such as a new TNF-alpha inhibitor or a new factor Xa-inhibiting oral anticoagulant). The process will help NICE to appraise new technologies efficiently, supporting patients and clinicians in accessing a broader range of treatment options. By adopting a practical and pragmatic approach, NICE can appraise technologies efficiently by avoiding unnecessary analysis and assessment."

Details are available here.  The consultation closes on the 24th August.